Haemonetics Corp (HAE)
83.47
-1.41
(-1.66%)
USD |
NYSE |
Apr 18, 16:00
83.47
0.00 (0.00%)
After-Hours: 20:00
Haemonetics Price to Book Value: 4.494 for April 18, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
April 17, 2024 | 4.570 |
April 16, 2024 | 4.532 |
April 15, 2024 | 4.570 |
April 12, 2024 | 4.588 |
April 11, 2024 | 4.658 |
April 10, 2024 | 4.638 |
April 09, 2024 | 4.687 |
April 08, 2024 | 4.593 |
April 05, 2024 | 4.557 |
April 04, 2024 | 4.570 |
April 03, 2024 | 4.518 |
April 02, 2024 | 4.532 |
April 01, 2024 | 4.565 |
March 28, 2024 | 4.595 |
March 27, 2024 | 4.527 |
March 26, 2024 | 4.395 |
March 25, 2024 | 4.405 |
March 22, 2024 | 4.322 |
March 21, 2024 | 4.323 |
March 20, 2024 | 4.297 |
March 19, 2024 | 4.173 |
March 18, 2024 | 4.080 |
March 15, 2024 | 4.028 |
March 14, 2024 | 4.070 |
March 13, 2024 | 4.11 |
Date | Value |
---|---|
March 12, 2024 | 4.138 |
March 11, 2024 | 4.219 |
March 08, 2024 | 4.286 |
March 07, 2024 | 4.186 |
March 06, 2024 | 4.170 |
March 05, 2024 | 4.119 |
March 04, 2024 | 4.026 |
March 01, 2024 | 3.993 |
February 29, 2024 | 3.929 |
February 28, 2024 | 4.031 |
February 27, 2024 | 3.999 |
February 26, 2024 | 3.942 |
February 23, 2024 | 3.958 |
February 22, 2024 | 4.032 |
February 21, 2024 | 3.945 |
February 20, 2024 | 3.846 |
February 16, 2024 | 3.896 |
February 15, 2024 | 3.870 |
February 14, 2024 | 3.835 |
February 13, 2024 | 3.860 |
February 12, 2024 | 4.025 |
February 09, 2024 | 3.995 |
February 08, 2024 | 4.205 |
February 07, 2024 | 4.151 |
February 06, 2024 | 4.151 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
3.061
Minimum
Jan 27 2022
11.90
Maximum
Aug 16 2019
6.408
Average
5.293
Median
Price to Book Value Benchmarks
Stryker Corp | 6.700 |
Boston Scientific Corp | 5.132 |
ResMed Inc | 5.827 |
Abbott Laboratories | 4.732 |
Insulet Corp | 15.71 |
Price to Book Value Related Metrics
PE Ratio | 33.93 |
PS Ratio | 3.374 |
PEG Ratio | 1.029 |
Price to Free Cash Flow | 33.29 |
Price | 83.47 |
Earnings Yield | 2.95% |
Market Cap | 4.239B |
PEGY Ratio | 1.029 |
Operating PE Ratio | 23.78 |
Normalized PE Ratio | 32.02 |